Navigation Links
A new way of looking at molecular motors

An innovative method of categorizing myosin--one of three molecular "motors" that produce movement within the cells of the body--has dramatically increased the amount of information available about these essential proteins, laying groundwork for development of treatments for conditions ranging from certain kinds of blindness and kidney disease to neurodegenerative disorders and parasitic diseases such as malaria.

All complex organisms use myosin and its relatives, kinesin and dynein, to move substances around inside cells and to help cells move from one place to the other. Myosins also help parasites enter and infect hosts. Defects in the motors play a role in a variety of human and animal disorders, including retinitis pigmentosa (which causes blindness), polycystic kidney disease, brain development defects, neurodegenerative diseases, muscular dystrophy, skin pigmentation problems, and genetic hearing loss.

Researchers led by Dominique Soldati, a Howard Hughes Medical Institute (HHMI) international research scholar at the University of Geneva in Switzerland, have developed a new system of classifying myosins. Up to now, researchers have only studied approximately 130 myosins at a time. The new system includes 250 myosins and increases the number of myosin subclasses from 18 to 24, enabling researchers to better understand each myosin's function.

"Myosins that belong to the same class work in similar ways but can have very different functions," explained Soldati. "We will have to discover the myosins' functions one by one, and the better we understand how they are related, the faster that will occur."

The new classification system also describes common evolutionary links between subclasses and protein components within myosins themselves. It includes myosins from insects, algae, parasites, and animals that have not been studied before.

The work will appear in the Proceedings of the National Academy of Sciences, with adva nce online publication February 6, 2006. Bernardo Foth, a postdoctoral fellow in Soldati's laboratory, is the first author.

Soldati and Foth became interested in myosins after they discovered that the molecular motors enabled toxoplasmosis and malaria parasites to force their way into human cells.

The researchers say that although their research is theoretical and a long way from clinical applications, the new classification system will help other researchers address important biomedical puzzles more precisely.

"We hope our work will help scientists ask the right questions and perform the right kind of experiments on myosins," Foth said. "In the long term, that could lead to new drug targets being discovered more quickly."

Molecular motors run on tracks, like trains, using chemical reactions that involve the chemical compound adenosine triphosphate (ATP) for fuel. Myosin runs on the filaments of actin, a protein found in muscle cells, but kinesins and dyneins use microtubules, which are hollow protein structures inside the cell, as their track.

Movement is created several ways. Biological cargo is transported within cells by single motors that run backward and forward, the way a person moves hand over hand along a rope. Making muscles contract involves a large number of motors that work very fast in neatly arranged teams, quickly letting go of the track once they have completed their "power stroke."

Most molecular motors have a head, a neck (which powers movement), and a tail. Myosins usually look like two-headed snakes, kinesins like hairpins with a head at each end, and dyneins like three-headed flowers with one stem. Soldati and Foth have confirmed that the motor neck and tail evolved together. That finding helped them define some of their new categories.

Organisms employ all three types of motors at the same time, but in different proportions. For example, yeast uses six kinesins, five myosins, and one dynein while mammals have genes for more than 40 kinesins, 40 myosins and more than a dozen dyneins.

Genetic and acquired defects in the motors cause disease by preventing developing cells from migrating to their necessary destinations before birth or by preventing parts of the body, such as sperm tails or the tiny hairs that keep mucus flowing in the lungs, from moving when they are supposed to. The motors in parasitic organisms contribute to disease by enabling the parasites to break through biological barriers within the human body and actively invade cells.

So far, molecular motors have been found in all organisms but bacteria, red algae, and the parasite Giardia. The new myosin classification system should help cell biologists, biochemists, biophysicists, parasitologists, and medical researchers make advances in a wide variety of fields, from veterinary medicine to tropical diseases.


Source:Howard Hughes Medical Institute

Related biology news :

1. Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression
2. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
3. Source of molecular triggers in cutaneous T cell lymphoma identified
4. Plants, animals share molecular growth mechanisms
5. NYU researchers simulate molecular biological clock
6. Scientists reveal molecular secrets of the malaria parasite
7. Scientists identify molecular events that drive cell senescence
8. Researchers discover molecular mechanism that desensitizes us to cold
9. Findings have implications for tracking disease, drugs at the molecular level
10. Successful Test Of Single Molecule Switch Opens The Door To Biomolecular Electronics
11. At the molecular level, the predator is the prey
Post Your Comments:

(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
(Date:4/14/2016)... BioCatch ™, the global ... the appointment of Eyal Goldwerger as CEO. ... Goldwerger,s leadership appointment comes at a time of significant ... of its platform at several of the world,s largest ... unique cognitive and physiological factors, is a winner of ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today ... a patient who developed lymphedema after being treated for breast cancer benefitted from an ... paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... NEWPORT BEACH, Calif. , June 23, 2016 /PRNewswire/ ... offering new biological discoveries to the medical community, has ... and co-founder Matthew Nunez . "We ... provide us with the capital we need to meet ... funding will essentially provide us the runway to complete ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... has initiated coverage on the following equities: Infinity Pharmaceuticals ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ... Learn more about these stocks by accessing their free trade ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
Breaking Biology Technology: